| Title |
Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19
|
|---|---|
| Published in |
Critical Care, August 2020
|
| DOI | 10.1186/s13054-020-03209-6 |
| Pubmed ID | |
| Authors |
Hideta Nakamura, Takeshi Kinjo, Wakako Arakaki, Kazuya Miyagi, Masao Tateyama, Jiro Fujita |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 43 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 5 | 12% |
| Other | 4 | 9% |
| Researcher | 4 | 9% |
| Student > Bachelor | 3 | 7% |
| Student > Master | 3 | 7% |
| Other | 9 | 21% |
| Unknown | 15 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 26% |
| Biochemistry, Genetics and Molecular Biology | 4 | 9% |
| Immunology and Microbiology | 3 | 7% |
| Agricultural and Biological Sciences | 2 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Other | 6 | 14% |
| Unknown | 15 | 35% |